TS2319014837	drug 62 95	dipeptidyl peptidase IV inhibitor
TS2619014837	drug 256 300	inhibitor of dipeptidyl peptidase ( DPP ) IV
TS1319014837	treatedDisease 351 366	type 2 diabetes
TS619014837	food 1071 1075	food
TS319014837	food 1168 1181	high-fat diet
TS119014837	drug 2067 2076	LC15-0444
TS1519014837	food 2145 2158	High-fat diet
TS1119014837	drug 2202 2212	LC15-0444.
TS2419014837	sideeffect 2549 2557	headache
TS2219014837	sideeffect 2572 2581	dizziness
TS819014837	sideeffect 2590 2596	nausea
TS719014837	sideeffect 2605 2614	epistaxis
TS1419014837	sideeffect 2627 2647	increased heart rate
TS919014837	food 2874 2878	food
TS2119014837	drugEffect 3029 3076	increased active glucagon-like peptide-1 levels
TS519014837	mealTime 3077 3102	after a standardized meal
T1	drug 96 105	LC15-0444
T2	drug 231 240	LC15-0444
T3	drug 754 763	LC15-0444
T4	drug 510 519	LC15-0444
T5	drug 1729 1738	LC15-0444
R1	treat Arg1:T2 Arg2:TS1319014837	
R2	treat Arg1:TS2619014837 Arg2:TS1319014837	
T6	dosage 713 715	25
T7	dosage 718 720	50
T8	dosage 723 726	100
T9	dosage 729 732	200
T10	dosage 735 738	400
T11	dosage 744 750	600 mg
T12	dosage 1110 1116	100-mg
T13	dosage 2039 2051	50 to 400 mg
T14	dosage 2078 2084	200 mg
T15	drugEffect 2099 2106;2114 2129	inhibit DPP IV activity
R3	has_effect Arg1:TS119014837 Arg2:T15	
R4	no_effect_on_drug Arg1:TS1519014837 Arg2:TS1119014837	
T16	drug 2215 2224	LC15-0444
T17	drug 2706 2715	LC15-0444
T18	dosage 2765 2777	50 to 400 mg
T19	dosage 2911 2917	200 mg
T20	drug 2921 2930	LC15-0444
T21	drugEffect 2931 2940;2948 2963	inhibited DPP IV activity
R5	has_effect Arg1:T20 Arg2:T21	
T22	dosage 3017 3023	600-mg
T23	duration 2130 2142	for 24 hours
R6	has_effect Arg1:T20 Arg2:TS2119014837	
R7	after Arg1:TS519014837 Arg2:T20	
T24	drug 3105 3114	LC15-0444
